AFP and hepatocellular carcinoma: As expected, the HCCseek-23 random forest model provided good performance for identifying stage I and II HCC patients (n=196, 81% sensitivity, 83% specificity, and 0.79 AUC) and identifying early-stage AFP-negative HCC patients (n= 45, 93% sensitivity and 83% specificity, Supplementary Table 4).